Effects of calcium antagonists on contractions of chorionic arteries in normal and preeclampsia placenta

Journal of Korean Medical Science

Volumn 11, Issue 3, 1996, Pages 250-257

  Kook, Hyun ^a   Yoon, Young Don ^a   Baik, Yung Hong ^a  

^a Chonnam National University Medical School   (South Korea)

Author keywords

Calcium channel antagonist; Chorionic artery; Cyclic AMP; Cyclic GMP; Endothelium; Preeclampsia

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; CYCLIC AMP; CYCLIC GMP; POTASSIUM CHLORIDE; PROSTAGLANDIN F2 ALPHA;

ARTERY; ARTICLE; DRUG EFFECT; FEMALE; HUMAN; PATHOPHYSIOLOGY; PLACENTA; PREECLAMPSIA; PREGNANCY; VASCULARIZATION; VASOCONSTRICTION;

ARTERIES; CALCIUM CHANNEL BLOCKERS; CYCLIC AMP; CYCLIC GMP; DINOPROST; FEMALE; HUMANS; PLACENTA; POTASSIUM CHLORIDE; PRE-ECLAMPSIA; PREGNANCY; VASOCONSTRICTION;

EID: 0030158312     PISSN: 10118934     EISSN: None     Source Type: Journal    
DOI: 10.3346/jkms.1996.11.3.250     Document Type: Article

References (34)

1. 2+ versus organic calcium channel blockers on myogenic tone and agonist-induced responsiveness of blood vessels. Can J Physiol Pharmacol 1987; 65: 729-45.
2. Altura BM, Malaviya D, Reich CF, Orkin LR. Effects of vasoactive agents in isolated umbilical arteries and veins. Am J Physiol 1972; 222: 345-55.
3. Altura BM, Altura BT. Magnesium and contraction of arterial smooth muscle. Microvasc Res 1974; 7: 145-55.
4. Cauvin C, Loutzenhiser R, van Breemen C. Mechanisms of calcium antagonist-induced vasodilation. Annu Rev Pharmacol Toxicol 1983; 23: 373-96.
5. Dube GP, Baik YH, Schwartz A. Effects of novel calcium channel agonist dihydropyridine analogue, Bay K 8644, on pig coronary artery: biphasic mechanical response and paradoxical potentiation of contraction by diltiazem and nimodipine. J Cardivasc Pharmacol 1985; 7: 377 -89.
6. Dyer DC. The pharmacology of isolated sheep umbilical cord blood vessels. J Pharmacol Exp Ther 1970; 175: 565 -70.
7. Furchgott RF. Role of endothelium in responses of vascular smooth muscle. Circ Res 1983; 53: 557-73.
8. 2α and noradrenaline on calcium exchange and contraction in rat mesenteric arteries and their sensitivity to calcium entry blockers. Br J Pharmacol 1982; 75: 229-36.
9. + channels. J Pharmacol Exp Ther 1985; 234: 134-40.
10. Jones JB, Rowsell A. Fetal 5-hydroxytryptamine levels in late pregnancy. J Obstet Gynecol 1973; 80: 687-9.
11. 45Ca uptake and release different sites in rabbit aortic smooth muscle. Pflugers Arch 1983; 398: 27-32.
12. Levine BS, Coburn JW. Magnesium, the mimic/antagonist of calcium [Editorial]. N Engl J Med 1984; 310: 1253-5.
13. Lunell NO, Nylund LE, Lewander R, Sarby B. Uteroplacental blood flow in preeclampsia. Measurements with indium 113 m and a computer-link gamma camera. Clin Exp Hypertens 1982; B1: 105-17.
14. Maigaard S, Forman A, Andersson K-E. Differential effects of angiotensin, vasopressin and oxytocin on various smooth muscle tissue within the human uteroplacental unit. Acta Physiol Scand 1986; 128: 23-32.
15. 2α on isolated human peripheral arteries and veins. Acta Pharmacol Toxicol 1978; 48: 398-404.
16. Montenegro R, Knuppel RA, Shan D, O'Brien WF. The effect of serotonergic blockade in postpartum preeclamptic patients. Am J Obstet Gynecol 1985; 153: 130-4.
17. Nadler JL, Goodson S, Rude R. Evidence that prostacyclin mediates the vascular action of magnesium in humans. Hypertension 1987; 9: 379-83.
18. Nasu T. Effects of cadmium ions on contraction in smooth muscle. Gen Pharmacol 1984; 15: 281-6.
19. Parisi VM, Walsh SW. Fetoplacental vascular responses to prostacyclin after thromboxane-induced vasoconstriction. Am J Obstet Gynecol 1989; 160: 502-7.
20. Reilly FD, Russell PT. Neurohistochemical evidence supporting an absence of adrenergic and cholinergic innervation in the human placenta and umbilical cord. Anat Rec 1977; 188: 277-86.
21. 2+ antagonists nifedipine and diltiazem on isolated human chorionic arteries and veins. J Cardiovasc Pharmacol 1990; 16: 128-38.
22. Romero R, Lockwood C, Oyarzun E, Hobbins JC. Toxemia: new concepts in an old disease. Semin Perinatol 1988; 12: 302-23.
23. Saida K. Intracellular Ca release in skinned smooth muscle. J Gen Physiol 1982; 80: 191-202.
24. Sanchez-Ferrer CS, Marin J. Endothelium-derived contractile factors. Gen Pharmacol 1990; 21: 589-603.
25. Schwartz A, Taira N. Calcium channel-blocking drugs: a novel intervention for the treatment of cardiac disease. Circ Res 1983; 52: 1-183.
26. 2 analog U46619 in human uteroplacental arteries in term pregnancy. Am J Obstet Gynecol 1990; 139: 1323-32.
27. Spedding M, Paoletti R. Classification of calcium channels and the sites of action of drugs modifying channel function. Pharmacol Rev 1992; 44: 363-76.
28. Toda N. Influene of cadmium ions on contractile response of isolated aortas to stimulatory agents. Am J Physiol 1973; 225: 350-5.
29. 2+ channels. Naunyn Schmiedeberg's Arch Pharmacol. 1989; 340: 437-41.
30. Walker DW, McLean JR. Absence of adrenergic nerves in the human placenta. Nature 1971; 229: 344-5.
31. Walsh SW. Preeclampsia: an imbalance in placental prostacyclin and thromboxane production. Am J Obstet Gynecol 1985; 152: 335-40.
32. Walters BNJ, Redmann CWG. Treatment of severe pregnancy-associated hypertension with the calcium antagonist nifedipine. Br J Obstet Gynecol 1984; 91: 330-6.
33. Watson KV, Moldow CF, Ogburn PL, Jacob HS. Magnesium sulfate rationale for its use in preeclampsia. Proc Natl Acad Sci USA 1986; 83: 1075-8.
34. Yatani A, Kunze DL, Brown AM. Effects of dihydropyridine calcium channel on cardiac sodium channels. Am J Physiol 1988; 254: H140-7.